SEC Form 4 · accession 0001104659-18-049251
Nabriva Therapeutics plc · NBRV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Harrison Talbot
Director
Period of report
Jul 31, 2018
Accepted (ET)
Aug 2, 2018 · 5:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 31, 2018 | P | 14,500 | $2.75 | A | 47,640 | D |
Table II — derivative securities
No Table II lines on this filing.